Rhea-AI Summary
BioDelivery Sciences International (BDSI) reported a robust first quarter of 2020, with total net sales increasing by 94% year-over-year to $38.3 million. BELBUCA® sales surged 79% to $33.5 million, driven by an all-time high of 99,400 prescriptions, a 52% increase from last year. The company's positive cash flow stood at $6.7 million, and GAAP net income reached $5.0 million, an improvement from net losses in the prior year. However, BUNAVAIL sales fell sharply, and the company has withdrawn its 2020 sales guidance due to COVID-19 uncertainties.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.18%
Tags